All articles about

A federal judge has denied in full a discovery request by GlaxoSmithKline (GSK) to subpoena documents from plaintiffs in the Zantac multidistrict litigation, with the judge stating that he had “serious questions” regarding the relevance of the evidence being subpoenaed. Among other things, GSK was looking to find out how the plaintiff was funded and by whom.

Before You Go

Never miss a thing in the litigation finance market.